Skip to main content
Figure 5 | Journal of Experimental & Clinical Cancer Research

Figure 5

From: A novel oncolytic viral therapy and imaging technique for gastric cancer using a genetically engineered vaccinia virus carrying the human sodium iodide symporter

Figure 5

Nuclear imaging of GLV-1 h153-infected MKN-74 xenografts. A. 99mTc pertechnetate scanning was performed 48 hours after infection and 3 hours after radiotracer administration. Tumors treated with GLV-1 h153 virus are clearly visualized (arrow). The stomach and thyroid are seen due to native expression of NIS, and the bladder is seen from excretion of the radiotracer. B. Axial, coronal, and sagittal views of an 124I PET image 48 hour after GLV-1 h153 injection shows enhanced signal in GLV-1 h153-infected MKN-74 tumors (arrow).

Back to article page